![Michael Beaubaire](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Michael Beaubaire
Directeur/Membre du Conseil chez Erad Therapeutics, Inc.
Profil
Michael Beaubaire is currently a director at Erad Therapeutics, Inc. He was previously the Chairman-Scientific Advisory Board at Lincoln Park Capital LLC from 2011 to 2018.
He also served as a director at Applied BioSciences Corp.
Dr. Beaubaire holds a doctorate degree from Northwestern University and undergraduate degrees from The Wharton School of the University of Pennsylvania and The College of Arts & Sciences.
Postes actifs de Michael Beaubaire
Sociétés | Poste | Début |
---|---|---|
Erad Therapeutics, Inc. | Directeur/Membre du Conseil | 01/05/2016 |
Anciens postes connus de Michael Beaubaire
Sociétés | Poste | Fin |
---|---|---|
Lincoln Park Capital LLC
![]() Lincoln Park Capital LLC Investment ManagersFinance Lincoln Park Capital LLC (Lincoln Park Capital) is a private equity/venture capital firm founded in 2010 by Joshua B. Scheinfeld, Jonatham I.Cope, Richard C. Vogel and Robert A. Garcia. The firm is headquartered in Chicago, Illinois. | Private Equity Investor | 28/02/2018 |
APPLIED BIOSCIENCES CORP. | Directeur/Membre du Conseil | - |
Formation de Michael Beaubaire
Northwestern University | Doctorate Degree |
The College of Arts & Sciences | Undergraduate Degree |
The Wharton School of the University of Pennsylvania | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 1 |
---|---|
APPLIED BIOSCIENCES CORP. | Health Technology |
Entreprise privées | 2 |
---|---|
Lincoln Park Capital LLC
![]() Lincoln Park Capital LLC Investment ManagersFinance Lincoln Park Capital LLC (Lincoln Park Capital) is a private equity/venture capital firm founded in 2010 by Joshua B. Scheinfeld, Jonatham I.Cope, Richard C. Vogel and Robert A. Garcia. The firm is headquartered in Chicago, Illinois. | Finance |
Erad Therapeutics, Inc. |